- Financial assistance: 51 percent of patients want it, but only 10 percent receive it.
- Measuring and tracking alerts, such as monitoring of blood glucose levels: 35 percent of patients want it, but only 20 percent receive it
- Product information: 53 percent of patients want it, and 48 percent say they receive such information.
A new Accenture (NYSE: ACN) survey of 2,000 patients in the United States taking long-term, short-term or lifestyle medications found that the vast majority (76 percent) believe pharmaceutical companies should provide services that complement the products they provide. The survey – Why Pharma Companies Can’t Ignore Patient Services – also uncovered significant gaps in the services that patients want and those that they are currently receiving. Those that do receive patient services – from participation in rewards programs to receipt of product information and financial assistance – value them greatly and are eager to use them. Yet the survey also indicates that for many customers these programs are not available. While 63 percent of the patients surveyed say they want to participate in customer rewards programs, only 10 percent say they have been offered the opportunity to do so. According to the survey, other services that patients most expect or want but are not receiving are: